The security staff members have been replaced with military personnel until their test results are available, and Lee assured a news conference that the potential outbreak would have
no effect on security at the Games.
Pastors preached about her brand and her type of music, politicians could not help but pass commentary about her, lawmakers contemplated her endeavours as an artiste with some making audacious assertions of her brand and music having some ripple
effect on security.
In as much as I would agree that the police officer be transferred from Asante Akim North as early as possible to restore confidence in the police and also to heal the psychological trauma that this police officer and his family went through in the hands of this probable lunatic in the name of DCE and politics, the DCE should be made to understand the implications of his uncouth behaviour towards the District Police Commander and its ripple
effects on the security situation on the people of Asante Akim North.
The statement further noted that the current happenings in Togo would not only destabilize the country but would have a rippling
effect on the security of its neighboring countries particularly Ghana.
It is certainly worth acknowledging that the way that the security procedures are designed and implemented will have a significant
effect on the security culture at the site, and, done poorly, can create significant legal risks to the organisation.
The proper use of this document can have a direct and dramatic
effect on the security of your business.
According to Microsoft's Value Indicator chart, these updates should improve compatibility and performance, with
no effect on security, reliability, connectivity, or battery life.
Social support had a stronger
effect on security of attachment in the context of irritable babies, such that when infants were temperamentally difficult, mothers who felt unsupported were more likely to have insecurely attached infants than mothers who felt supported.
Motivation has been shown to have
an effect on the security of attachment of infants in care.
Once they come on board, their cyber security practices could have a direct
effect on the security of your business.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses
on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the
effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the
effect of global economic conditions
on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the
effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact
on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact
on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other
security attacks, information technology failures, or other disruptions; 16) returns
on pension plan assets and the impact of future discount rate changes
on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco
on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the
effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the
effect of changes in tax law, such as the
effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted
on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the
effect of such changes; 21) any reduction in our credit ratings; 22) our dependence
on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments
on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest
on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed
on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side
effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report
on Form 10 - K and in subsequent filings made by the company with the U.S.
Securities and Exchange Commission («SEC»), which are available
on the SEC's website at www.sec.gov.
«These investments are having a detrimental
effect on our political stability and worsening the relationship between our federal government and the regions,» said former deputy national
security adviser Hussein Sheikh - Ali.
While the loss of the city has no immediate
effect on oil exports, now at over three million barrels a day, it adds to concerns over
security and the country's plans to expand oil production.
The Australian
Securities Exchange has softened the changes to its listing requirements for companies wishing to trade
on the stock market, with the new rules to take
effect from next month.
New
security measures take
effect on Thursday
on all U.S. - bound flights to comply with government requirements designed to avoid an in - cabin ban
on laptops.
You also need to consider the
effects that early retirement can have
on your Social
Security benefits.
Either way, the privacy rules were enacted
on a limited basis in January, while a provision that would generally require ISPs to «engage in reasonable data
security practices» in the event of
security breaches was set to go into legal
effect on March 2.
Drew McReynolds of RBC Dominion
Securities said that while Esso accounts for an undisclosed fraction of the 10 to 12 per cent gross billings from non-financial and non-Air Canada partners, the minimal financial impact doesn't convey the overall
effect on Aeroplan as it prepares for the departure of Air Canada.
It's clear that Mueller's team «is being very strategic and are trying to preempt efforts that have the
effect of insulating the administration from the investigations,» said Jon Michaels, a professor at UCLA School of Law and an expert
on national
security law.
the government's decisions
on everything from program cuts to the national
securities regulator will have an
effect.
New
security measures including stricter passenger screening take
effect on Thursday
on all U.S. - bound flights to comply with government requirements designed to avoid an in - cabin ban
on laptops, airlines said.
But brokerage firm UBS
Securities doesn't think Apple's new feature will have anywhere near that kind of
effect on mobile advertising.
Daniel Hanson, an analyst for Height
Securities, told Morning Consult that the current default likely won't have a major
effect on the municipal bond market because its
effects were already «priced in» ahead of time.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required
on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the
effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact
on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S.
Securities and Exchange Commission (the SEC).
SAN FRANCISCO (Reuters)- U.S. Department of Homeland
Security Secretary Kirstjen Nielsen warned
on Tuesday that a European data privacy law taking
effect next month may have «unintended consequences» that harm the United States» ability to protect itself from cyber attacks.
Title II of the Jumpstart Our Business Startups Act (JOBS Act), which went into
effect today, has lifted the ban
on «general solicitation» of investments by companies that rely
on a widely used regulatory exemption to issue
securities.
One institution having too much influence
on the rating of
securities can have damaging
effects.
The U.S.
Securities and Exchange Commission's (SEC) regulation crowdfunding (or equity crowdfunding) rules went into
effect on May 16, 2016.
SAN FRANCISCO U.S. Department of Homeland
Security Secretary Kirstjen Nielsen warned
on Tuesday that a European data privacy law taking
effect next month may have «unintended consequences» that harm the United States» ability to protect itself from cyber attacks.
Furthermore, the rates at which these
securities, by investors can buy and sell have little
effect on their prices.
Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential
effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and
security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger;
effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report
on Form 10 - K and subsequent reports
on Forms 10 - Q and 8 - K available
on the Investor Relations section of www.cigna.com as well as
on Express Scripts» most recent report
on Form 10 - K and subsequent reports
on Forms 10 - Q and 8 - K available
on the Investor Relations section of www.express-scripts.com.
«Based
on previous overseas research (Goldman Sachs (2016) etc.), at the
Securities sector (exchange and depository), the back office cost (IT cost, labor, etc.) will have a reduction
effect of 107.7 billion won (16 % of total cost) as of 2015.»
In - depth analyses of elite and public opinion survey data from the United States and China
on a wide range of
security issues provide nuanced and far - reaching insights into the potential
effects of these attitudes
on the U.S. - China relationship.
Bond fund withdrawals might have had a greater
effect on markets where there is less trading, such as municipal
securities — but even there, redemptions from bond funds would have accounted for less than 10 percent of the primary dealers» trading.
The earnings test does not apply to this group — that is, seniors who have reached full retirement age can earn as much as possible with no
effect on their Social
Security benefits.
The increased exposure and excitement surrounding residential
security, the smart home and other automation technology has had a profound
effect on the acquisitions market.
The above commentary is based
on Social
Security laws in
effect as of July 2014.
Section 232 of the Trade Expansion Act of 1962, as amended, gives the executive branch the ability to conduct investigations to «determine the
effects on the national
security of imports.»
in the case of our directors, officers, and
security holders, (i) the receipt by the locked - up party from us of shares of Class A common stock or Class B common stock upon (A) the exercise or settlement of stock options or RSUs granted under a stock incentive plan or other equity award plan described in this prospectus or (B) the exercise of warrants outstanding and which are described in this prospectus, or (ii) the transfer of shares of Class A common stock, Class B common stock, or any
securities convertible into Class A common stock or Class B common stock upon a vesting or settlement event of our
securities or upon the exercise of options or warrants to purchase our
securities on a «cashless» or «net exercise» basis to the extent permitted by the instruments representing such options or warrants (and any transfer to us necessary to generate such amount of cash needed for the payment of taxes, including estimated taxes, due as a result of such vesting or exercise whether by means of a «net settlement» or otherwise) so long as such «cashless exercise» or «net exercise» is
effected solely by the surrender of outstanding stock options or warrants (or the Class A common stock or Class B common stock issuable upon the exercise thereof) to us and our cancellation of all or a portion thereof to pay the exercise price or withholding tax and remittance obligations, provided that in the case of (i), the shares received upon such exercise or settlement are subject to the restrictions set forth above, and provided further that in the case of (ii), any filings under Section 16 (a) of the Exchange Act, or any other public filing or disclosure of such transfer by or
on behalf of the locked - up party, shall clearly indicate in the footnotes thereto that such transfer of shares or
securities was solely to us pursuant to the circumstances described in this bullet point;
Section 232 investigations help to determine the
effects of imports
on America's national
security and give the President the ability to address any threats to national...
The positive
effects appear to depend
on workplace policies and norms that support cooperation and higher effort, such as employee involvement in decisions, participation in company training, and job
security.
Once in
effect, the exemption will allow listed reporting issuers (excluding investment funds) to raise capital from existing
security holders
on a cost effective basis.
In a 4 - 1 vote today by the U.S.
Securities and Exchange Commission (SEC), an amendment has passed to lift the 80 year ban
on the general solicitation and advertising of Regulation D («Reg D») offerings which will go into
effect in 60 days.
If
securities analysts or investors perceive these results to be negative, it could have a substantial adverse
effect on the trading price of our Class A common stock.
A podcast about the impact of artificial intelligence and its
effect on society, job
security, and the future of the human race.
11742), relating to identification of critical infrastructure where a cybersecurity incident could reasonably result in catastrophic regional or national
effects on public health or safety, economic
security, or national
security.
12) To better secure each News Company's rights under this guarantee and Indemnity, each guarantor agrees to charge the interest they have either solely or jointly or as tenants in common in any real estate and personal assets, and each guarantor acknowledges a News Company's right pursuant to the
security hereby given lodge a caveat
on any real estate in which they have such as interest and each guarantor agrees to execute a mortgage in favour of any News Company upon request by a News Company and do or cause to be done all such things as are necessary to give
effect to the
security hereby given.
These rules took
effect on March 1, as the Basel Committee
on Banking Supervision and the International Organization of
Securities Commissions (BCBS - IOSCO) had mandated.
These risks and uncertainties include: fluctuations in U.S. and international economies and currencies, our ability to preserve, grow and leverage our brands, potential negative
effects of material breaches of our information technology systems if any were to occur, costs associated with, and the successful execution of, the company's initiatives and plans, the acceptance of the company's products by our customers, the impact of competition, coffee, dairy and other raw material prices and availability, the
effect of legal proceedings, and other risks detailed in the company filings with the
Securities and Exchange Commission, including the «Risk Factors» section of Starbucks Annual Report
on Form 10 - K for the fiscal year ended September 28, 2014.